Retinopathy of prematurity: Future vision and challenges by Saleem, Taimur
INDIAN  PEDIATRICS 817 VOLUME 46__SEPTEMBER 17, 2009
C O R R E S P O N D E N C E
I read with interest the paper by Chaudhari, et al.(1)
in the March 2009 issue of Indian Pediatrics and
would like to congratulate the authors for broaching
and researching on retinopathy of prematurity
(ROP). Oxygen administration, septicemia and
apnea were found to be the significant risk factors
reported. This is in agreement with a retrospective
study from Pakistan at a tertiary care centre where
sepsis, duration of supplemental oxygen therapy,
mechanical ventilation and respiratory distress
syndrome were found to be significantly associated
with the development of ROP(2).In a study from a
tertiary care centre in Nepal, oxygen supplemen-
tation was identified as an independent risk factor for
ROP(3). It is important to collect more data from the
developing world to quantify the true burden of this
disease. This should dictate the future resources
allocated for this problem. Meanwhile, the need for
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the development and execution of an effective and
successful screening program in developing coun-
tries can not be overemphasized.
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harsh environments of digestive and respiratory
tracts. As it is abundant in secretions like tears, saliva
and mucosal linings, it is also the first antibody to
come in contact with different antigens(1). Bovine
and human SIgA is found to be homologous and
colostrum have identified as a rich source of
SIgA(2). SIgA is said to act as blocking and  neutra-
lizing antibody and also inhibit potential harmful
activation of proinflammatory B pathway in the
epithelium and enhance stromal clearance of
antigen-NF that has breached the mucosal barrier(3).
However, in those with IgA deficiency, there may be
potential harmful IgG antibodies against cows’ milk
and ruminant serum proteins and against IgA. If the
anti-IgA antibodies are of the IgE type, there may be
fatal anaphylactic reactions after transfusion of
blood and blood products(1). Hence, only specially
washed RBCs or blood from IgA deficient
Bovine Colostrum in those
with Immunodeficiency
Pediatricians often meet the challenge of taking care
of children with recurrent infections. Gastrointes-
tinal and respiratory infections are the causes of
recurrent morbidity and significant mortality among
children in developing countries. IgA is important in
protecting the surface tracts like digestive and
respiratory tracts and IgA deficiency, even though
often transient, is the most common immunodefi-
ciency(1). The use of bovine colostrum rich in IgA is
being advised in children for prevention and
treatment of various conditions(2). The rationale
behind this is the fact that secretory IgA (SIgA) can
resist proteolytic degradation and can survive in the
